Jin X, Liu T, Xu J et al (2019) Exogenous GABA enhances muskmelon tolerance to salinity-alkalinity stress by regulating redox balance and chlorophyll biosynthesis
Key trends include the growing adoption of oral semaglutide, expanded approvals for obesity management, and strong pipeline developments in advanced GLP-1 formulations
For type 2 diabetes, GLP-1 receptor agonists are typically long-term therapies, similar to blood pressure or cholesterol medications
Uncertain Long-Term Effects: As GIP medications are relatively new, long-term side effects are still being studied
it doesn't initiate it
Evidence from Spanish outpatient settings shows 77.1% of users achieving HbA1c targets below 7%, along with mean weight loss of 9.72 kg, standards now referenced by Mexican specialists